William S. Dalton

Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma

Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster et al. · New England Journal of Medicine · 2005 · 2.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro et al. · Immunity · 1999 · 1.7K citations · Full text

Life Sciences, Cancer Biology, Cell Biology +16

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

Tianhong Wang, Guilian Niu, Marcin Kortylewski et al. · Nature Medicine · 2003 · 1.1K citations

Life Sciences, Cancer Biology, Immunology +14

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study

Shaji Kumar, J H Lee, Juan José Lahuerta et al. · Leukemia · 2011 · 721 citations

Medicine, Hematology, Pharmacotherapy +15

MicroRNA-155 Is Regulated by the Transforming Growth Factor β/Smad Pathway and Contributes to Epithelial Cell Plasticity by Targeting RhoA

William Kong, Hua Yang, Lili He et al. · Molecular and Cellular Biology · 2008 · 689 citations · Full text

Life Sciences, Molecular Biology, Oncology +17